podofilox

Action and Spectrum

Drug Interaction

Adverse Reaction

Adverse drug reactions  

Frequency Defined  

>10%  

Erosion (44-48%)  

Inflammation (63%)  

Bleeding (22%)  

Burning (63%)  

Pruritus (44-48%)  

Pain (44-48%)  

1-10%  

Dizziness  

Stinging (7%)  

Erythema (5%)  

Hematuria  

Headache (6-9%)  

Insomnia  

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy warnings:   

Pregnancy: C  

Lactation:  

Excreted into human milk is unknown 

Pregnancy Categories:        

Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.   

Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.  

Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.    

Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.    

Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.    

Category N: There is no data available for the drug under this category

Pharmacology

Adminstartion

Patient Information Leaflet

Patient Information Leaflet    

Generic Name: podofilox 

Why do we use podofilox?  

podofilox is an Keratolytic Agents used to treat Anogenital Warts.